{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:07:26Z","timestamp":1774350446573,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Program Management Unit for Competitiveness","award":["189773-C02F680003"],"award-info":[{"award-number":["189773-C02F680003"]}]},{"name":"Naresuan University (NU) and National Science, Research and Innovation Fund","award":["R2567B026"],"award-info":[{"award-number":["R2567B026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12602-025-10678-0","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:49:48Z","timestamp":1753436988000},"page":"2202-2219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bifidobacterium longum TISTR 2893 Regulates Glycemic Homeostasis by Modulating the Hepatic Carbohydrate Metabolism in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats"],"prefix":"10.1007","volume":"18","author":[{"given":"Kanokpron","family":"Tasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pennapa","family":"Chonpathompikunlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navinee","family":"Wongmanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worarat","family":"Rojanaverawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suthkamol","family":"Suttikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tantima","family":"Kumlung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanyarat","family":"Lekchaoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanthanee","family":"Hanchang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"10678_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S et al (2022) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"10678_CR2","doi-asserted-by":"publisher","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S et al (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21176275","DOI":"10.3390\/ijms21176275"},{"key":"10678_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M et al (2023) Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 168:115734. https:\/\/doi.org\/10.1016\/j.biopha.2023.115734","journal-title":"Biomed Pharmacother"},{"key":"10678_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri B, Dey S, Das T et al (2018) Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother 107:306\u2013328. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.157","journal-title":"Biomed Pharmacother"},{"key":"10678_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-023-01043-8","volume":"55","author":"J Son","year":"2023","unstructured":"Son J, Accili D (2023) Reversing pancreatic beta-cell dedifferentiation in the treatment of type 2 diabetes. Exp Mol Med 55:1652\u20131658. https:\/\/doi.org\/10.1038\/s12276-023-01043-8","journal-title":"Exp Mol Med"},{"key":"10678_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00210-018-1583-4","volume":"392","author":"ME Abdelmageed","year":"2019","unstructured":"Abdelmageed ME, Shehatou GS, Abdelsalam RA et al (2019) Cinnamaldehyde ameliorates STZ-induced rat diabetes through modulation of IRS1\/PI3K\/AKT2 pathway and AGEs\/RAGE interaction. Naunyn Schmiedebergs Arch Pharmacol 392:243\u2013258. https:\/\/doi.org\/10.1007\/s00210-018-1583-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10678_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/1750-3841.15109","volume":"85","author":"J Mu","year":"2020","unstructured":"Mu J, Xin G, Zhang B et al (2020) Beneficial effects of Aronia\u00a0melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats. J Food Sci 85:1307\u20131318. https:\/\/doi.org\/10.1111\/1750-3841.15109","journal-title":"J Food Sci"},{"key":"10678_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"10678_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110208","volume":"142","author":"A Zepeda-Hernandez","year":"2021","unstructured":"Zepeda-Hernandez A, Garcia-Amezquita LE, Requena T, Garcia-Cayuela T (2021) Probiotics, prebiotics, and synbiotics added to dairy products: uses and applications to manage type 2 diabetes. Food Res Int 142:110208. https:\/\/doi.org\/10.1016\/j.foodres.2021.110208","journal-title":"Food Res Int"},{"key":"10678_CR10","doi-asserted-by":"publisher","unstructured":"Al-Ishaq RK, Samuel SM, Busselberg D (2023) The influence of gut microbial species on diabetes mellitus. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24098118","DOI":"10.3390\/ijms24098118"},{"key":"10678_CR11","doi-asserted-by":"publisher","unstructured":"Zhai L, Wu J, Lam YY et al (2021) Gut-microbial metabolites, probiotics and their roles in type 2 diabetes. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222312846","DOI":"10.3390\/ijms222312846"},{"key":"10678_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3920\/BM2014.0014","volume":"5","author":"LK Stenman","year":"2014","unstructured":"Stenman LK, Waget A, Garret C et al (2014) Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef Microbes 5:437\u2013445. https:\/\/doi.org\/10.3920\/BM2014.0014","journal-title":"Benef Microbes"},{"key":"10678_CR13","doi-asserted-by":"publisher","unstructured":"Zhang J, Wang S, Zeng Z et al (2020) Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model. J Funct Foods 67:103843. https:\/\/doi.org\/10.1016\/j.jff.2020.103843","DOI":"10.1016\/j.jff.2020.103843"},{"key":"10678_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1017\/s0007114511004491","volume":"107","author":"J Chen","year":"2012","unstructured":"Chen J, Wang R, Li XF, Wang RL (2012) Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr 107:1429\u20131434. https:\/\/doi.org\/10.1017\/s0007114511004491","journal-title":"Br J Nutr"},{"key":"10678_CR15","doi-asserted-by":"publisher","unstructured":"Qian X, Si Q, Lin G et al (2022) Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity. Nutrients 14. https:\/\/doi.org\/10.3390\/nu14122479","DOI":"10.3390\/nu14122479"},{"key":"10678_CR16","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1271\/bbb.100267","volume":"74","author":"S Kondo","year":"2010","unstructured":"Kondo S, Xiao JZ, Satoh T et al (2010) Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 74:1656\u20131661. https:\/\/doi.org\/10.1271\/bbb.100267","journal-title":"Biosci Biotechnol Biochem"},{"key":"10678_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2019.108792","volume":"129","author":"M Ben Othman","year":"2020","unstructured":"Ben Othman M, Sakamoto K (2020) Effect of inactivated Bifidobacterium longum intake on obese diabetes model mice (TSOD). Food Res Int 129:108792. https:\/\/doi.org\/10.1016\/j.foodres.2019.108792","journal-title":"Food Res Int"},{"key":"10678_CR18","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1111\/1750-3841.16727","volume":"88","author":"K Gao","year":"2023","unstructured":"Gao K, Ren X, Chen C et al (2023) Oral administration of Bifidobacterium longum WHH2270 ameliorates type 2 diabetes in rats. J Food Sci 88:3967\u20133983. https:\/\/doi.org\/10.1111\/1750-3841.16727","journal-title":"J Food Sci"},{"key":"10678_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-023-10156-5","author":"WJ Kim","year":"2023","unstructured":"Kim WJ, Ryu R, Doo EH et al (2023) Supplementation with the probiotic strains Bifidobacterium longum and Lactiplantibacillus\u00a0rhamnosus alleviates glucose intolerance by restoring the IL-22 response and pancreatic beta cell dysfunction in type 2 diabetic mice. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-023-10156-5","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10678_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00592-018-1175-2","volume":"55","author":"N Kassaian","year":"2018","unstructured":"Kassaian N, Feizi A, Aminorroaya A et al (2018) The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial. Acta Diabetol 55:1019\u20131028. https:\/\/doi.org\/10.1007\/s00592-018-1175-2","journal-title":"Acta Diabetol"},{"key":"10678_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10377-2","author":"W Hanchang","year":"2024","unstructured":"Hanchang W, Dissook S, Wongmanee N et al (2024) Antidiabetic effect of Bifidobacterium animalis TISTR 2591 in a rat model of type 2 diabetes. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-024-10377-2","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10678_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2023.10.009","volume":"15","author":"EP Van Syoc","year":"2024","unstructured":"Van Syoc EP, Damani J, DiMattia Z et al (2024) The effects of Bifidobacterium probiotic supplementation on blood glucose: a systematic review and meta-analysis of animal models and clinical evidence. Adv Nutr 15:100137. https:\/\/doi.org\/10.1016\/j.advnut.2023.10.009","journal-title":"Adv Nutr"},{"key":"10678_CR23","doi-asserted-by":"publisher","unstructured":"Allende A, Alvarez\u2010Ord\u00f3\u00f1ez A, Bortolaia V et al (2025) Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 21: suitability of taxonomic units notified to EFSA until September 2024. EFSA Journal 23. https:\/\/doi.org\/10.2903\/j.efsa.2025.9169","DOI":"10.2903\/j.efsa.2025.9169"},{"key":"10678_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00394-024-03529-1","volume":"64","author":"K Pakaew","year":"2024","unstructured":"Pakaew K, Chonpathompikunlert P, Wongmanee N et al (2024) Lactobacillus reuteri TISTR 2736 alleviates type 2 diabetes in rats via the hepatic IRS1\/PI3K\/AKT signaling pathway by mitigating oxidative stress and inflammatory mediators. Eur J Nutr 64:27. https:\/\/doi.org\/10.1007\/s00394-024-03529-1","journal-title":"Eur J Nutr"},{"key":"10678_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jtcme.2023.08.005","volume":"14","author":"N Wongmanee","year":"2024","unstructured":"Wongmanee N, Rojanaverawong W, Boonsong T, Hanchang W (2024) Antihyperglycemic effect of extra virgin sacha inchi oil in type 2 diabetic rats: mechanisms involved in pancreatic beta-cell function and apoptosis. J Tradit Complement Med 14:148\u2013161. https:\/\/doi.org\/10.1016\/j.jtcme.2023.08.005","journal-title":"J Tradit Complement Med"},{"key":"10678_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3746\/pnf.2023.28.1.30","volume":"28","author":"W Rojanaverawong","year":"2023","unstructured":"Rojanaverawong W, Wongmanee N, Hanchang W (2023) Sacha Inchi (Plukenetia\u00a0volubilis L.) oil improves hepatic insulin sensitivity and glucose metabolism through insulin signaling pathway in a rat model of type 2 diabetes. Prev Nutr Food Sci 28:30\u201342. https:\/\/doi.org\/10.3746\/pnf.2023.28.1.30","journal-title":"Prev Nutr Food Sci"},{"key":"10678_CR27","doi-asserted-by":"publisher","first-page":"123286","DOI":"10.1007\/s11356-023-31066-7","volume":"30","author":"S Yoopum","year":"2023","unstructured":"Yoopum S, Wongmanee N, Rojanaverawong W et al (2023) Mango (Mangifera\u00a0indica L.) seed kernel extract suppresses hyperglycemia by modulating pancreatic beta cell apoptosis and dysfunction and hepatic glucose metabolism in diabetic rats. Environ Sci Pollut Res Int 30:123286\u2013123308. https:\/\/doi.org\/10.1007\/s11356-023-31066-7","journal-title":"Environ Sci Pollut Res Int"},{"key":"10678_CR28","doi-asserted-by":"publisher","unstructured":"Alaaeldin R, Abdel-Rahman IAM, Hassan HA et al (2021) Carpachromene ameliorates insulin resistance in HepG2 Cells via modulating IR\/IRS1\/PI3k\/Akt\/GSK3\/FoxO1 pathway. Molecules 26. https:\/\/doi.org\/10.3390\/molecules26247629","DOI":"10.3390\/molecules26247629"},{"key":"10678_CR29","doi-asserted-by":"publisher","first-page":"1531567","DOI":"10.1155\/2019\/1531567","volume":"2019","author":"P Kesika","year":"2019","unstructured":"Kesika P, Sivamaruthi BS, Chaiyasut C (2019) Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials. Biomed Res Int 2019:1531567. https:\/\/doi.org\/10.1155\/2019\/1531567","journal-title":"Biomed Res Int"},{"key":"10678_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW (2021) Adipose tissue and insulin resistance in obese. Biomed Pharmacother 137:111315. https:\/\/doi.org\/10.1016\/j.biopha.2021.111315","journal-title":"Biomed Pharmacother"},{"key":"10678_CR31","doi-asserted-by":"publisher","unstructured":"Gheibi S, Kashfi K, Ghasemi A (2017) A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother 95:605\u2013613. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.098","DOI":"10.1016\/j.biopha.2017.08.098"},{"key":"10678_CR32","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1039\/d0fo00180e","volume":"11","author":"D Zhao","year":"2020","unstructured":"Zhao D, Zhu H, Gao F et al (2020) Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice. Food Funct 11:6528\u20136541. https:\/\/doi.org\/10.1039\/d0fo00180e","journal-title":"Food Funct"},{"key":"10678_CR33","doi-asserted-by":"publisher","unstructured":"Zhu M, Yang L, Li L et al (2025) Administration of Bifidobacterium animalis subsp. lactis BLa80 and Lactobacillus acidophilus LA85 improved hyperglycemia and modulated gut microbiota in type 2 diabetic mice. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-025-10567-6","DOI":"10.1007\/s12602-025-10567-6"},{"key":"10678_CR34","doi-asserted-by":"publisher","first-page":"9947","DOI":"10.1039\/d2fo01109c","volume":"13","author":"J Hao","year":"2022","unstructured":"Hao J, Zhang Y, Wu T et al (2022) The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. Food Funct 13:9947\u20139958. https:\/\/doi.org\/10.1039\/d2fo01109c","journal-title":"Food Funct"},{"key":"10678_CR35","doi-asserted-by":"publisher","unstructured":"Zhang C, Fang B, Zhang N et al (2024) The effect of Bifidobacterium animalis subsp. lactis MN-gup on glucose metabolism, gut microbiota, and their metabolites in type 2 diabetic mice. Nutrients 16. https:\/\/doi.org\/10.3390\/nu16111691","DOI":"10.3390\/nu16111691"},{"key":"10678_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-511X-11-29","volume":"11","author":"C Moroti","year":"2012","unstructured":"Moroti C, Souza Magri LF, de Rezende CM et al (2012) Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 11:29. https:\/\/doi.org\/10.1186\/1476-511X-11-29","journal-title":"Lipids Health Dis"},{"key":"10678_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000349922","volume":"63","author":"Z Asemi","year":"2013","unstructured":"Asemi Z, Zare Z, Shakeri H et al (2013) Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 63:1\u20139. https:\/\/doi.org\/10.1159\/000349922","journal-title":"Ann Nutr Metab"},{"key":"10678_CR38","doi-asserted-by":"publisher","first-page":"e0317202","DOI":"10.1371\/journal.pone.0317202","volume":"20","author":"W Luangphiphat","year":"2025","unstructured":"Luangphiphat W, Prombutara P, Jamjuree P et al (2025) The efficacy of\n Lacticaseibacillus\n\n paracasei\n MSMC39-1 and\n Bifidobacterium\n\n animalis\n TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: a randomized, double-blinded, placebo-controlled study. PLoS ONE 20:e0317202. https:\/\/doi.org\/10.1371\/journal.pone.0317202","journal-title":"PLoS ONE"},{"key":"10678_CR39","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1530\/JOE-17-0516","volume":"236","author":"M Bensellam","year":"2018","unstructured":"Bensellam M, Jonas JC, Laybutt DR (2018) Mechanisms of beta-cell dedifferentiation in diabetes: recent findings and future research directions. J Endocrinol 236:R109\u2013R143. https:\/\/doi.org\/10.1530\/JOE-17-0516","journal-title":"J Endocrinol"},{"key":"10678_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2024.101834","volume":"40","author":"Z Ansari","year":"2024","unstructured":"Ansari Z, Maleki MH, Roohy F et al (2024) Protective effects of artichoke extract and Bifidobacterium longum on male infertility in diabetic rats. Biochem Biophys Rep 40:101834. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101834","journal-title":"Biochem Biophys Rep"},{"key":"10678_CR41","doi-asserted-by":"publisher","unstructured":"Niu X, Zhang Q, Zhang Y et al (2025) Effect of Bifidobacterium animalis subsp. lactis Langg JZ-08 on lipid metabolism in individuals with obesity and dyslipidemia: a randomised, double-blind, and placebo-controlled trial. Human Nutrition Metabol 40:200300. https:\/\/doi.org\/10.1016\/j.hnm.2025.200300","DOI":"10.1016\/j.hnm.2025.200300"},{"key":"10678_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD (2018) Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol 14:99\u2013114. https:\/\/doi.org\/10.1038\/nrendo.2017.173","journal-title":"Nat Rev Endocrinol"},{"key":"10678_CR43","unstructured":"Akshintala D, Chugh R, Amer F, Cusi K (2000) Nonalcoholic fatty liver disease: the overlooked complication of type 2 diabetes. In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. PMID: 31310460.\u00a0 Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544043\/"},{"key":"10678_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104984","volume":"159","author":"CH Zhang","year":"2020","unstructured":"Zhang CH, Zhou BG, Sheng JQ et al (2020) Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacol Res 159:104984. https:\/\/doi.org\/10.1016\/j.phrs.2020.104984","journal-title":"Pharmacol Res"},{"key":"10678_CR45","doi-asserted-by":"publisher","unstructured":"Do MH, Oh MJ, Lee HB et al (2022) Bifidobacterium animalis ssp. lactis MG741 reduces body weight and ameliorates nonalcoholic fatty liver disease via improving the gut permeability and amelioration of inflammatory cytokines. Nutrients 14. https:\/\/doi.org\/10.3390\/nu14091965","DOI":"10.3390\/nu14091965"},{"key":"10678_CR46","doi-asserted-by":"publisher","unstructured":"Kou R, Wang J, Li A et al (2023) Ameliorating effects of Bifidobacterium longum subsp. infantis FB3\u201314 against high-fat-diet-induced obesity and gut microbiota disorder. Nutrients 15. https:\/\/doi.org\/10.3390\/nu15194104","DOI":"10.3390\/nu15194104"},{"key":"10678_CR47","doi-asserted-by":"publisher","unstructured":"Li Z, Jin H, Oh SY, Ji GE (2016) Anti-obese effects of two Lactobacilli and two Bifidobacteria on ICR mice fed on a high fat diet. Biochem Biophys Res Commun 480:222\u2013227. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.031","DOI":"10.1016\/j.bbrc.2016.10.031"},{"key":"10678_CR48","doi-asserted-by":"publisher","unstructured":"Lu J, Shataer D, Yan H, et al (2024) Probiotics and non-alcoholic fatty liver disease: unveiling the mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in modulating lipid metabolism, inflammation, and intestinal barrier integrity. Foods 13. https:\/\/doi.org\/10.3390\/foods13182992","DOI":"10.3390\/foods13182992"},{"key":"10678_CR49","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1002\/fsn3.4279","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xu J, Dong X et al (2024) Bifidobacterium longum BL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. Food Sci Nutr 12:6442\u20136460. https:\/\/doi.org\/10.1002\/fsn3.4279","journal-title":"Food Sci Nutr"},{"key":"10678_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/469059","volume":"2014","author":"T Ren","year":"2014","unstructured":"Ren T, Huang C, Cheng M (2014) Dietary blueberry and Bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway. Oxid Med Cell Longev 2014:1\u201312. https:\/\/doi.org\/10.1155\/2014\/469059","journal-title":"Oxid Med Cell Longev"},{"key":"10678_CR51","doi-asserted-by":"publisher","unstructured":"Zhao H, Zhou J, Yuan L et al (2025) Exploring the alleviating effects of Bifidobacterium metabolite lactic acid on non-alcoholic steatohepatitis through the gut-liver axis. Front Microbiol 15. https:\/\/doi.org\/10.3389\/fmicb.2024.1518150","DOI":"10.3389\/fmicb.2024.1518150"},{"key":"10678_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.coph.2020.10.016","volume":"55","author":"S Guerra","year":"2020","unstructured":"Guerra S, Gastaldelli A (2020) The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes. Curr Opin Pharmacol 55:165\u2013174. https:\/\/doi.org\/10.1016\/j.coph.2020.10.016","journal-title":"Curr Opin Pharmacol"},{"key":"10678_CR53","doi-asserted-by":"publisher","unstructured":"Boucher J, Kleinridders A, Kahn CR (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 6. https:\/\/doi.org\/10.1101\/cshperspect.a009191","DOI":"10.1101\/cshperspect.a009191"},{"key":"10678_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P et al (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785\u2013789. https:\/\/doi.org\/10.1038\/378785a0","journal-title":"Nature"},{"key":"10678_CR55","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z (2018) The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14:1483\u20131496. https:\/\/doi.org\/10.7150\/ijbs.27173","journal-title":"Int J Biol Sci"},{"key":"10678_CR56","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tem.2024.05.006","volume":"35","author":"E Barroso","year":"2024","unstructured":"Barroso E, Jurado-Aguilar J, Wahli W et al (2024) Increased hepatic gluconeogenesis and type 2 diabetes mellitus. Trends Endocrinol Metab 35:1062\u20131077. https:\/\/doi.org\/10.1016\/j.tem.2024.05.006","journal-title":"Trends Endocrinol Metab"},{"key":"10678_CR57","doi-asserted-by":"publisher","unstructured":"Dou Y, Huang R, Li Q, et al (2021) Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K\/Akt and Nrf2 signaling pathways. Biomedicine & Pharmacotherapy 137:111312. https:\/\/doi.org\/10.1016\/j.biopha.2021.111312","DOI":"10.1016\/j.biopha.2021.111312"},{"key":"10678_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114556","volume":"281","author":"S Govindarajan","year":"2021","unstructured":"Govindarajan S, Babu SN, Vijayalakshmi MA et al (2021) Aloe vera carbohydrates regulate glucose metabolism through improved glycogen synthesis and downregulation of hepatic gluconeogenesis in diabetic rats. J Ethnopharmacol 281:114556. https:\/\/doi.org\/10.1016\/j.jep.2021.114556","journal-title":"J Ethnopharmacol"},{"key":"10678_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172657","volume":"862","author":"BM Patel","year":"2019","unstructured":"Patel BM, Goyal RK (2019) Liver and insulin resistance: new wine in old bottle!!! Eur J Pharmacol 862:172657. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172657","journal-title":"Eur J Pharmacol"},{"key":"10678_CR60","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.181156","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y, Ren Y, Zhang Y et al (2018) Protective role of nano-selenium-enriched Bifidobacterium longum in delaying the onset of streptozotocin-induced diabetes. R Soc Open Sci 5:181156. https:\/\/doi.org\/10.1098\/rsos.181156","journal-title":"R Soc Open Sci"},{"key":"10678_CR61","doi-asserted-by":"publisher","unstructured":"Ma L, Zheng A, Ni L et al (2022) Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-Fat diet-Induced obese mice. Mol Nutr Food Res 66:e2100639. https:\/\/doi.org\/10.1002\/mnfr.202100639","DOI":"10.1002\/mnfr.202100639"},{"key":"10678_CR62","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.csbj.2021.03.006","volume":"19","author":"G Alessandri","year":"2021","unstructured":"Alessandri G, van Sinderen D, Ventura M (2021) The genus Bifidobacterium: from genomics to functionality of an important component of the mammalian gut microbiota. Comput Struct Biotechnol J 19:1472\u20131487. https:\/\/doi.org\/10.1016\/j.csbj.2021.03.006","journal-title":"Comput Struct Biotechnol J"},{"key":"10678_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2021.100993","volume":"41","author":"M Sharma","year":"2021","unstructured":"Sharma M, Wasan A, Sharma RK (2021) Recent developments in probiotics: an emphasis on Bifidobacterium. Food Biosci 41:100993. https:\/\/doi.org\/10.1016\/j.fbio.2021.100993","journal-title":"Food Biosci"},{"key":"10678_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/life14020239","volume":"14","author":"GH Hizo","year":"2024","unstructured":"Hizo GH, Rampelotto PH (2024) The impact of probiotic Bifidobacterium on liver diseases and the microbiota. Life 14:239. https:\/\/doi.org\/10.3390\/life14020239","journal-title":"Life"},{"key":"10678_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108780","volume":"38","author":"S Mozaffari","year":"2024","unstructured":"Mozaffari S, Aliari M, Emamgholipour S et al (2024) The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Complicat 38:108780. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108780","journal-title":"J Diabetes Complicat"},{"key":"10678_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/jcm9020369","volume":"9","author":"A Sroka-Oleksiak","year":"2020","unstructured":"Sroka-Oleksiak A, M\u0142odzi\u0144ska A, Bulanda M et al (2020) Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: a pilot study. J Clin Med 9:369. https:\/\/doi.org\/10.3390\/jcm9020369","journal-title":"J Clin Med"},{"key":"10678_CR67","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.chom.2024.07.017","volume":"32","author":"DP Baars","year":"2024","unstructured":"Baars DP, Fondevila MF, Meijnikman AS, Nieuwdorp M (2024) The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes. Cell Host Microbe 32:1280\u20131300. https:\/\/doi.org\/10.1016\/j.chom.2024.07.017","journal-title":"Cell Host Microbe"},{"key":"10678_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.103666","volume":"64","author":"D Xavier-Santos","year":"2020","unstructured":"Xavier-Santos D, Bedani R, Lima ED, Saad SMI (2020) Impact of probiotics and prebiotics targeting metabolic syndrome. J Funct Foods 64:103666. https:\/\/doi.org\/10.1016\/j.jff.2019.103666","journal-title":"J Funct Foods"},{"key":"10678_CR69","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/jam.12573","volume":"117","author":"S-H Kim","year":"2014","unstructured":"Kim S-H, Huh C-S, Choi I-D et al (2014) The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo. J Appl Microbiol 117:834\u2013845. https:\/\/doi.org\/10.1111\/jam.12573","journal-title":"J Appl Microbiol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10678-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:58:17Z","timestamp":1774342697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10678-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10678"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10678-0","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"11 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}